Clinical Advances in Treatment for Venous Thromboembolism
A special issue of Journal of Clinical Medicine (ISSN 2077-0383). This special issue belongs to the section "Hematology".
Deadline for manuscript submissions: 25 January 2026 | Viewed by 1867
Special Issue Editors
Interests: venous thromboembolism; thrombophilia; anticoagulation; hospital-acquired condition; cancer-associated thrombosis; pregnancy and thrombophilia
Special Issue Information
Dear Colleagues,
Venous thromboembolism (VTE), comprising deep vein thrombosis (DVT) and pulmonary embolism (PE), is a common and potentially fatal disease. The management strategies for VTE have changed dramatically over the past decade, and these changes include the introduction of direct oral anticoagulants (DOACs) for thromboprophylaxis and other treatments. A key concern in treating VTE is determining the optimal duration of anticoagulation in order to prevent its recurrence. According to recent evidence, this should be tailored to each patient by weighing up the risk of a recurrence of VTE and the risk of bleeding. Although there have been significant advances in VTE management, several uncertainties continue to challenge clinicians in everyday practice, such as VTE associated with cancer, VTE in unusual-sites, antiphospholipid syndrome, and minor cases, such as subsegmental pulmonary embolism and distal deep vein thrombosis. These areas require further research, and several clinical trials are currently underway to address them. While DOACs have quickly supplanted VKAs and have led to a significant rise in the global use of anticoagulant medications due to their effectiveness, safety, and ease of use, the risk of bleeding remains a concern, as is the case with all anticoagulant treatments. In response to this unmet clinical need, research has begun to focus on novel targets within the coagulation cascade. This Special Issue will be devoted to these topics, and we invite all interested authors to submit papers on “Clinical Advances in Treatment for Venous Thromboembolism”.
Dr. Elisavet Grouzi
Dr. Georgia Kaiafa
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- venous thromboembolism
- anticoagulation
- cancer-associated thrombosis
- thrombosis in MPNs
- thrombosis in multiple myeloma
- antiphospholipidic syndrome
- thrombosis in PNH
- thrombosis in hemoglobinopathies
- thrombophilia
- pregnancy and thrombophilia
- reversal of anticoagulants
- thromboprophylaxis
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
